NVCR
NASDAQ
$16
NovoCure Ltd (NVCR)
NovoCure Limited, an oncology company, is engaged in the development, manufacture and marketing of Optune for the treatment of a variety of solid tumors. The company is headquartered in Saint Helier, Jersey.
Sector:
Healthcare
Industry:
Medical Devices
Buy
Target: $24.88 (+55.50%)
Market Cap
$1.86B
Free Cash Flow Yield
-3.14%
Beta (5Y)
1.37
Price Chart
Valuation
Market Cap$1.86B
Forward P/E909.09
P/S2.67
P/B5.45
Profitability
Total Revenue (TTM)$1.16B
Gross Profit (TTM)$509M
EBITDA-$271M
Profit Margin-40.9%
Operating Margin-38.7%
EPS-$2.52
Financial Health
Free Cash Flow Yield-3.14%
Growth & Risk
Revenue 5Y CAGR+18.95%
Beta (5Y)1.37
Sharpe Ratio0.31